About Tulip Diagnostics
Tulip Diagnostics is a Healthcare company based in Panaji (India) founded in 1988 by Gihan Wijesinghe and Vinayak Naik, and was acquired by PerkinElmer in January 2017. IVD kits and instruments for infectious diseases and clinical chemistry. The company has 1,416 employees. Tulip Diagnostics has completed 1 acquisition, including Biosense. Its chief executive, as recorded, is Gihan Wijesinghe. Its website tulipgroup.com draws about 11 thousand monthly visits. Its Indian entity Tulip Diagnostics Private Limited reported revenue of ₹553 Cr. Tulip Diagnostics offers products and services including In-vitro Diagnostic Kits, Clinical Chemistry Reagents, Disinfectants, and Microbiology Range. Its focus areas include Diversified Diagnostics and Tests.
Company details
Tulip Group offers in IVD kits and instruments for infectious diseases and clinical chemistry. The company offers a wide range of products that include Immunohaematology reagents, Immunology reagents, and Insight range (Hepatitis range, HBV range, and Drug of Abuse). The companys primary focus lies in immunohematology, hematology, rheumatology, infectious diseases, hemostasis, and instrumentation. The company has divisions under the names Orchid Biomedical Systems, Qualpro Diagnostics, Zephyr Biomedicals, BioShields, Microxpress, Viola Diagnostic Systems, and Coral Clinical Systems. Orchid Biomedical Systems, Qualpro Diagnostics, Zephyr Biomedicals focuses on rapid membrane ELISA based immunodiagnostic platforms along with chemiluminescence. Viola Diagnostic Systems deals with rapid immunoassays for parasitology range and infectious diseases. Coral Clinical Systems focuses on clinical biochemistry and instrumentation while its division BioShields deals with antiseptics and disinfectants for industrial, medical and domestic use. Microxpress focuses on dehydrated culture media, bases, supplements, reagent and test kits, sterile ready prepared plates, antimicrobial susceptibility discs, plant tissue culture media and chemicals for microbiology and mycobacteriology.
- Headquarters Panaji, India
- Employees 1,416
- Founders Gihan Wijesinghe, Vinayak Naik
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website tulipgroup.com
- Social LinkedIn
- Acquired by PerkinElmer (Jan 2017)
- Legal Name Tulip Diagnostics Private Limited
- Date of Incorporation 14 Dec, 1988
- Jurisdiction Tiswadi, Goa, India
- Annual Revenue₹553 Cr
FY 2024 · +5% YoY
- Net Profit₹52.27 Cr
FY 2024 · 9% margin
- EBITDA₹129 Cr
FY 2024 · 23% margin
- Investors
- Employee Count1,416
- Investments & Acquisitions
- Acquired byPerkinElmer
(Jan 2017)
Associated legal entities of Tulip Diagnostics
Tulip Diagnostics operates through Tulip Diagnostics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Tulip Diagnostics Private Limited CIN U85195GA1988PTC005717 | Active | 14 Dec 1988 | Tiswadi, Goa | ₹553 Cr | 1,416 | 3 | View details |
Products & Services of Tulip Diagnostics
Tulip Diagnostics offers a comprehensive portfolio of products and services, including In-vitro Diagnostic Kits, Clinical Chemistry Reagents, Disinfectants, and Microbiology Range.
Kits for blood banking and serology testing in healthcare
Reagents for clinical chemistry analysis and controls
Products for hand and surface disinfection purposes
Items like culture media and stains for lab testing
Investors in Tulip Diagnostics
Tulip Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include PerkinElmer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Medical instruments and supplies are manufactured and provided for healthcare. | 1931 | perkinelmer.com | Waltham, United States |
Investor details for Tulip Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Tulip Diagnostics Private Limited (Tulip Diagnostics)
Tulip Diagnostics Private Limited is the primary company behind Tulip Diagnostics. The board of Tulip Diagnostics Private Limited currently have 3 directors; the longest-serving is Alok Kumar, appointed in 2017. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Alok Kumar DIN 05119699 | Director | 31 Jan 2017 | 9 yrs 8 mo | Tulip Diagnostics Private Limited |
| Deepak Gurushankar Tripathi DIN 02021472 | Director | 05 May 2017 | 9 yrs 5 mo | Tulip Diagnostics Private Limited |
| Narendra Makkar DIN 07940889 | Director | 19 Sep 2017 | 9 yrs 1 mo | Tulip Diagnostics Private Limited |
People of Tulip Diagnostics
2 people are tracked at Tulip Diagnostics (2 in leadership); the tracked headcount is 1,416.
| Name | Role | Group |
|---|---|---|
Gihan Wijesinghe | Founder & CEO | Leadership |
| Founder & Director | Leadership |
Complete people profiles for Tulip Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Tulip Diagnostics
Figures of Tulip Diagnostics Private Limited, the primary company behind Tulip Diagnostics, for FY 2024. Revenue was ₹553 Cr (+5% year on year). Net profit was ₹52.27 Cr (9% margin). EBITDA was ₹129 Cr (23% margin). Revenue has grown at a compounded annual rate of +9% over three years and +11% over five years.
- ₹553 CrRevenue · FY 2024 · +5% YoY
- ₹52.27 CrNet profit · 9% margin
- ₹129 CrEBITDA · 23% margin
- ₹2.16 CrPaid-up capital
- 1,416Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Tulip Diagnostics Private Limited are on its company page.
Detailed financial statements for Tulip Diagnostics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tulip Diagnostics
Tulip Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Biosense.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Diagnostic devices for multiple diseases are developed and provided. | biosense.in | Mumbai, India | 2008 | Nov 2019 | •••• |
Complete acquisition details for Tulip Diagnostics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Tulip Diagnostics
3 dated milestones of Tulip Diagnostics across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Tulip Diagnostics is founded.
- Exit Acquired by PerkinElmer.
- Acquisition Acquires Biosense.
Web traffic of Tulip Diagnostics
The website of Tulip Diagnostics (tulipgroup.com) receives about 10.7K visits a month.
- Monthly visits10.7K
▼ 0.8% vs previous month
Websites whose visitors overlap most with Tulip Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| stat-technologies.com | 100% | #2,785,214 | View details | ||
| atlas-medical.com | 100% | 19.7K | #1,416,805 | View details | |
| agappe.com | 99% | 46.2K | #740,353 | View details | |
| medzell.net | 88% | 32.6K | #1,024,709 | View details | |
| fortressdiagnostics.com | 81% | #3,973,986 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tulip Diagnostics
Complete news archive for Tulip Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tulip Diagnostics
Tulip Diagnostics was founded in 1988.
Tulip Diagnostics is headquartered in Panaji, India. It is registered at Panaji, Goa, India.
Gihan Wijesinghe is the CEO of Tulip Diagnostics, as recorded in our data. They have also founded this company.
Tulip Diagnostics has 1,416 employees.
The primary company behind Tulip Diagnostics, Tulip Diagnostics Private Limited, reported revenue of ₹553 Cr for FY 2024, up 5% year on year.
Tulip Group offers in IVD kits and instruments for infectious diseases and clinical chemistry. The company offers a wide range of products that include Immunohaematology reagents, Immunology reagents, and Insight range (Hepatitis range, HBV range, and Drug of Abuse). The companys primary focus lies in immunohematology, hematology, rheumatology, infectious diseases, hemostasis, and instrumentation. The company has divisions under the names Orchid Biomedical Systems, Qualpro Diagnostics, Zephyr Biomedicals, BioShields, Microxpress, Viola Diagnostic Systems, and Coral Clinical Systems. Orchid Biomedical Systems, Qualpro Diagnostics, Zephyr Biomedicals focuses on rapid membrane ELISA based immunodiagnostic platforms along with chemiluminescence. Viola Diagnostic Systems deals with rapid immunoassays for parasitology range and infectious diseases. Coral Clinical Systems focuses on clinical biochemistry and instrumentation while its division BioShields deals with antiseptics and disinfectants for industrial, medical and domestic use. Microxpress focuses on dehydrated culture media, bases, supplements, reagent and test kits, sterile ready prepared plates, antimicrobial susceptibility discs, plant tissue culture media and chemicals for microbiology and mycobacteriology.
Tulip Diagnostics offers In-vitro Diagnostic Kits, Clinical Chemistry Reagents, Disinfectants, and Microbiology Range.
Tulip Diagnostics has made 1 acquisition, including Biosense.
Tulip Diagnostics has 1 investor. Key investors include PerkinElmer.
Tulip Diagnostics operates through Tulip Diagnostics Private Limited.
Yes. Tulip Diagnostics was acquired by PerkinElmer in January 2017.
The legal entities of Tulip Diagnostics currently have 3 directors, including Alok Kumar, Narendra Makkar, Deepak Gurushankar Tripathi.